What is Humana's revenue?

Humana (HUM) generated $137.20B in revenue over the trailing twelve months, up 14.1% year over year.

Is Humana profitable?

Humana reported $3.2B in net income over the trailing twelve months, a 3.0% net margin.

What is Humana's earnings per share?

Humana's diluted EPS over the trailing twelve months is $26.26.

Where does Humana's income statement data come from?

Every line is extracted from Humana's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Humana HUM Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Net premiums earned	$37.71B+23.6%	$30.88B+11.3%	$30.71B+9.9%	$30.72B+9.1%	$30.51B+8.0%
Total revenue	$39.65B+23.5%	$32.52B+11.3%	$32.65B+11.1%	$32.39B+9.6%	$32.11B+8.4%
Selling, general and administrative	$4.02B+19.1%	$4.44B+6.5%	$4.09B+22.3%	$3.55B+12.7%	$3.38B+11.1%
Compensation and benefits	$51M+4.1%	——	$83M+56.6%	$61M+10.9%	$49M+8.9%
Impairment charges	——	$96M-52.0%	——	$32M—	——
Other operating expenses	$21M+200%	——	$27M-15.6%	-$7M-164%	$7M-78.8%
Operating income	$1.75B-12.9%	——	$400M-45.1%	$1.1B-3.8%	$2.01B+62.9%
Operating margin	4.4%-1.8pp	——	1.2%-1.3pp	3.4%-0.5pp	6.3%+2.1pp
Interest expense	$193M+20.6%	$146M-11.0%	$168M-0.6%	$157M-6.5%	$160M+0.6%
Interest income	$262M-0.8%	$132M-55.6%	$338M-1.5%	$272M-8.7%	$264M-8.3%
Other income (expense), net	$34M+121%	-$53M+65.8%	-$35M-138%	-$200M-264%	-$163M-159%
Income from equity method investments	-$16M+62.8%	-$14M+62.2%	-$26M-62.5%	-$19M-11.8%	-$43M-79.2%
Net investment gains (losses)	-$1M-150%	——	$53M+430%	$11M+1,200%	$2M+100%
Income before income taxes	$1.6B-5.7%	——	$134M-78.9%	$741M-17.8%	$1.69B+70.8%
Income tax expense	$395M-2.7%	——	-$86M-155%	$179M-19.7%	$406M+61.8%
Net income	$1.19B-4.7%	——	$195M-59.4%	$545M-19.7%	$1.24B+67.9%
Net margin	3%-0.9pp	——	0.6%-1.0pp	1.7%-0.6pp	3.9%+1.4pp
Net income attributable to noncontrolling interests	-$2M0.0%	——	-$1M—	-$2M-100%	-$2M0.0%
Preferred stock dividends	$107M—	——	——	——	——
Diluted earnings per share	$9.83-4.6%	——	$1.62-59.3%	$4.51-19.8%	$10.30+68.6%
Basic earnings per share	$9.85-4.5%	——	$1.62-59.4%	$4.52-19.7%	$10.31+68.2%
Weighted-average shares, diluted	120.7M-0.2%	——	120.7M0.0%	120.7M+0.1%	120.8M-0.3%
Weighted-average shares, basic	120.3M-0.3%	——	120.3M-0.1%	120.5M+0.1%	120.7M-0.3%
Investment and other income	$262M-0.8%	$132M-55.6%	$338M-1.5%	$272M-8.7%	$264M-8.3%
Net investment income	$262M-0.8%	——	$338M-1.5%	$272M-8.7%	$264M-8.3%
Policyholder Benefits And Claims Incurred Net	$33.71B+27.0%	$28.72B+13.2%	$27.99B+11.4%	$27.57B+10.1%	$26.54B+5.6%
Adjustment For Amortization	$11M-26.7%	——	$13M-13.3%	$15M0.0%	$15M-6.3%
Share-based compensation expense related to employee stock plans	$51M+2.0%	——	$83M+56.6%	$60M+9.1%	$50M+11.1%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	2.3M+28.6%	——	450K+24.7%	791K+5.3%	1.8M+55.1%
Benefits, Losses and Expenses	$37.89B+25.9%	$33.32B+12.0%	$32.25B+12.5%	$31.29B+10.2%	$30.1B+6.1%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$751M-63.0%	——	$1.35B—	——	$2.03B+66.9%
Cash dividend per common share (in dollars per share)	$0.890.0%	——	$0.890.0%	$0.890.0%	$0.890.0%
Dividends declared (in dollars per share)	$0.890.0%	——	——	——	$0.890.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$1.09B-24.6%	——	$312M-67.1%	$630M-2.0%	$1.44B+121%
Gross gains on investment securities	$2M-60.0%	——	$54M+286%	$13M—	$5M+150%
Debt And Equity Securities, Realized Loss	$3M0.0%	——	$1M-75.0%	$2M+100%	$3M+200%
Depreciation	$183M-8.5%	$186M-17.7%	$191M-16.2%	$196M-14.0%	$200M-11.5%
Depreciation and amortization classified as benefit expense	$31M-6.1%	——	$30M-6.3%	$32M0.0%	$33M+3.1%
Dividends, Common Stock, Cash	$108M0.0%	——	$106M-0.9%	$107M0.0%	$108M0.0%
Effective tax rates	$0.25+1.6%	——	-$0.77-417%	$0.250.0%	$0.25-2.8%
Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Maturities	$0-100%	——	——	——	$2M—
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3	$14M—	——	——	——	$0—
Purchases	$50M-20.6%	——	$10M-68.8%	$8M-72.4%	$63M+473%
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3	$14M—	——	——	——	$0—
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	$23M—	——	$0—	$0—	$0—
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	$0—	——	$1M-75.0%	$0—	$0-100%
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1	$0—	——	$0—	$0—	$0—
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss	-$1M-133%	——	$7M0.0%	——	$3M+250%
Fair Value Of Assets Acquired	$966M—	$85M+13.3%	$4M-82.6%	$2M-50.0%	$0-100%
Goodwill Additions	$803M—	——	$3M-87.0%	$2M-50.0%	$0-100%
Member co-share amounts and government subsidies	$4.3B+34.4%	——	$3.7B-33.9%	$3.3B-31.3%	$3.2B-20.0%
Change in book overdraft	-$9M+72.7%	-$2M-104%	——	-$72M-427%	-$33M-65.0%
Increase (Decrease) in Collateral Held under Securities Lending	-$55M-131%	——	$93M-67.0%	——	$175M—
Increase (decrease) in contract liabilities and current deferred income	-$87M-1,840%	$91M—	$0+100%	$9M-25.0%	$5M-85.7%
Benefits payable	$2.72B+169%	——	-$971M—	——	$1.01B-32.1%
Increase (Decrease) in Other Operating Assets	$1.39B+103%	$799M+207%	$716M—	$0+100%	$686M+807%
Other liabilities	$452M+134%	$5M—	$307M+280%	$817M—	$193M+146%
Changes in rebate factor payable	$0+100%	——	——	-$55M—	-$68M—
Increase Decrease In Receivables	$1.91B+9.1%	——	-$1.82B—	$45M-72.7%	$1.76B-7.1%
Changes in securities lending payable	-$55M-131%	——	$93M-67.0%	——	$175M—
Interest Paid, Excluding Capitalized Interest, Operating Activity	$142M-0.7%	$188M+11.9%	$147M-11.4%	$150M+63.0%	$143M-9.5%
Liabilities Assumed1	$55M—	$9M-60.9%	$0-100%	$1M0.0%	$0-100%
Current year	$23B+30.6%	——	$28.64B+14.6%	$27.21B+12.3%	$17.61B+9.6%
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	$33.71B+27.0%	——	$27.99B+11.4%	$27.57B+10.1%	$26.54B+5.6%
Prior years	$7.98B+0.8%	——	$320M-27.8%	$743M-32.4%	$7.92B+4.5%
Maximum individual state general bond obligation as a percentage of total debt securities (as percent)	1%0.0%	——	——	——	1%0.0%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$2.05B+48.1%	-$168M+92.7%	-$603M+21.7%	-$1.83B-195%	$1.38B+14.7%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$2.55B-913%	$632M+1,103%	$980M+167%	$347M+135%	$314M+176%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$1.25B+279%	——	$971M-47.7%	$1.27B+4.8%	$331M-21.7%
Net Income Loss Attributable To Noncontrolling Interest	-$2M0.0%	——	-$1M—	-$2M-100%	-$2M0.0%
Net Investment Income	$262M-0.8%	——	$338M-1.5%	$272M-8.7%	$264M-8.3%
Distribution to noncontrolling interest holders, net	-$12M—	——	——	-$5M-350%	——
Number of reportable segments	20.0%	——	——	——	20.0%
Other comprehensive income (loss)	-$98M-149%	——	$117M-75.1%	$85M+336%	$199M+329%
Other comprehensive income/(loss)	-$98M-149%	——	$117M-75.1%	$85M+336%	$199M+329%
Tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from AOCI for sale of securities	$0-100%	——	$11M+450%	$0—	$1M—
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax	$1M0.0%	——	$33M+313%	$5M+600%	$1M0.0%
Other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Before Tax	$1M-50.0%	——	$44M+340%	$5M+600%	$2M+100%
Tax expense (benefit) of unrealized gains/losses on available for sale securities still held	-$26M-145%	——	$45M-68.3%	$27M+370%	$58M+307%
Net unrealized gains (losses) on securities still held	-$97M-149%	——	$150M-68.6%	$90M+343%	$200M+333%
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax	-$123M-148%	——	$195M-68.5%	$117M+349%	$258M+326%
Other income, net (Note 6)	$34M+121%	-$53M+65.8%	-$35M-138%	-$200M-264%	-$163M-159%
All other operating activities	$21M+200%	-$27M-184%	$27M-15.6%	-$7M-164%	$7M-78.8%
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	$30.98B+21.4%	——	$28.96B+13.8%	$27.96B+10.4%	$25.52B+8.0%
Payments For (Proceeds From) Contract Deposits	-$673M-2,023%	——	$585M-36.6%	$544M—	$35M+107%
Payments for Repurchase of Common Stock	$107M+1,089%	$42M-14.3%	$0-100%	$100M+104%	$9M-98.7%
Payments of Debt Issuance Costs	$0-100%	——	——	$2M0.0%	$3M-40.0%
Payments of Dividends	$107M-0.9%	$109M+0.9%	$107M0.0%	$106M-0.9%	$108M-0.9%
Payments to Acquire Debt Securities, Available-for-Sale	$2.89B+250%	$1.24B-42.0%	$3.26B+3.1%	$1.11B-31.4%	$827M-34.3%
Payments to Acquire Businesses, Net of Cash Acquired	$911M—	$76M+46.2%	$4M-80.0%	$1M-66.7%	$0-100%
Payments to Acquire Property, Plant, and Equipment	$121M+27.4%	$202M+31.2%	$135M+3.8%	$114M0.0%	$95M-46.3%
Debt issued (Note 13)	$990M-33.2%	——	——	——	$1.48B—
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale	$923M+3.8%	$764M-0.5%	$531M-38.2%	$728M+2.5%	$889M+37.8%
Financing — other	-$18M-50.0%	-$5M+37.5%	-$14M-100%	-$50M+21.9%	-$12M+58.6%
Net change in commercial paper	$693M+17,425%	——	——	-$1M+99.6%	-$4M+99.4%
Sale of investments	$395M-24.3%	$1.44B-10.8%	$3.82B+204%	$721M+568%	$522M+33.5%
Repayments of Long-Term Debt	$10M—	——	——	——	$0—
Stock-based compensation	$51M+4.1%	$48M-11.1%	$83M+56.6%	$61M+10.9%	$49M+8.9%
Common shares acquired in connection with employee stock plans, amount	$5M-44.4%	——	$1M-50.0%	——	$9M-40.0%
Common shares acquired in connection with employee stock plans (in shares)	20K-33.3%	——	——	——	30K-25.0%
Restricted stock acquisition consideration	$0—	——	$0—	$0—	$0—
Prior years	-$389M+18.4%	——	-$275M-1,046%	-$161M-20.1%	-$477M+10.8%
Current year	$34.1B+26.2%	——	$28.27B+12.4%	$27.73B+10.1%	$27.01B+5.3%
Tangible Asset Impairment Charges	$2M-77.8%	$14M-87.0%	$0-100%	$5M-90.7%	$9M-72.7%
Treasury stock, value, acquired	$108M+1,100%	——	$1M0.0%	$100M+100%	$9M-98.8%
EBITDA	$1.92B-12.7%	——	$573M-38.9%	$1.28B-5.7%	$2.2B+52.0%
EBITDA margin	4.8%-2.0pp	——	1.8%-1.4pp	3.9%-0.6pp	6.8%+2.0pp
EBIT	$1.75B-12.9%	——	$400M-45.1%	$1.1B-3.8%	$2.01B+62.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Humana.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Humana's revenue?: Humana (HUM) generated $137.20B in revenue over the trailing twelve months, up 14.1% year over year.
Is Humana profitable?: Humana reported $3.2B in net income over the trailing twelve months, a 3.0% net margin.
What is Humana's earnings per share?: Humana's diluted EPS over the trailing twelve months is $26.26.
Where does Humana's income statement data come from?: Every line is extracted from Humana's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.